DePuy Synthes has acquired a 3D-printing technology for making skeletal reconstruction and bone regeneration scaffolds, a move that underscores the orthopedics market leader's focus on adding more individualized, patient-specific solutions to its trauma portfolio.
The bone-scaffold technology comes from Tissue Regeneration Systems Inc. (TRS), a privately held Michigan company with whom DePuy Synthes has...